Progesterone Receptor Negative Suspended Phase 1 Trials for Irinotecan (DB00762)

IndicationStatusPhase
DBCOND0038639 (Progesterone Receptor Negative)Suspended1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02631733Liposomal Irinotecan and Veliparib in Treating Patients With Solid TumorsTreatment